Altered Secretory Activity of APE1/Ref-1 D148E Variants Identified in Human Patients With Bladder Cancer
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1) is a multifunctional protein involved in DNA repair and redox modulation. Recently, serum and urinary APE1/Ref-1 levels were reported to be increased in patients with bladder cancer. Genetic variations of APE/Ref-1 are associated with the risk of cancer. However, the effect of APE1/Ref-1 variants on its secretory activity is yet unknown. Methods: APE1/Ref-1 variants were evaluated by DNA sequencing analysis of reverse transcription polymerase chain reaction products in coding DNA sequences (CDS) of APE1/Ref-1 in bladder tissue samples from patients with bladder cancer (n=10). Secretory activity of APE1/Ref-1 variants was evaluated with immunoblot and enzyme-linked immunosorbent assay of the culture medium supernatants. Results: Four different substitution mutants (D148E, I64V/D148E, W67R/D148E, and E86G/D148E) of APE1/Ref-1 were identified in bladder cancer specimens. However, deletion mutants of APE1/Ref-1 CDS were not found. The secretory activity of the APE1/Ref-1 variants (D148E, I64V/D148E, and E86G/D148E) was increased compared to that of wild type APE1/Ref- 1. Furthermore, the secretory activity in basal or hyperacetylated conditions was much higher than that in APE1/Ref-1 D148Etransfected HEK293 cells. Conclusions: Taken together, our data suggest that the increased secretory activity of D148E might contribute to increased serum levels of APE1/Ref-1 in patients with bladder cancer.
Abstract
Purpose: Apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1) is a multifunctional protein involved in DNA repair and redox modulation. Recently, serum and urinary APE1/Ref-1 levels were reported to be increased in patients with bladder cancer. Genetic variations of APE/Ref-1 are associated with the risk of cancer. However, the effect of APE1/Ref-1 variants on its secretory activity is yet unknown. Methods: APE1/Ref-1 variants were evaluated by DNA sequencing analysis of reverse transcription polymerase chain reaction products in coding DNA sequences (CDS) of APE1/Ref-1 in bladder tissue samples from patients with bladder cancer (n=10). Secretory activity of APE1/Ref-1 variants was evaluated with immunoblot and enzyme-linked immunosorbent assay of the culture medium supernatants. Results: Four different substitution mutants (D148E, I64V/D148E, W67R/D148E, and E86G/D148E) of APE1/Ref-1 were identified in bladder cancer specimens. However, deletion mutants of APE1/Ref-1 CDS were not found. The secretory activity of the APE1/Ref-1 variants (D148E, I64V/D148E, and E86G/D148E) was increased compared to that of wild type APE1/Ref- 1. Furthermore, the secretory activity in basal or hyperacetylated conditions was much higher than that in APE1/Ref-1 D148Etransfected HEK293 cells. Conclusions: Taken together, our data suggest that the increased secretory activity of D148E might contribute to increased serum levels of APE1/Ref-1 in patients with bladder cancer.
참고문헌 (25)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008", Cancer Research and Treatment, 43(1), pp.1~11 (2011), 대한암학회
- Harrison L, "Human apurinic endonuclease gene (APE): structure and genomic mapping (chromosome 14q11.2-12)", Hum Mol Genet, 1, pp.677~680 (1992)
- Jeon BH, "APE1", Ref-1: versatility in progress, 2009, pp.11, 571~
- Park JS, "Human AP endonuclease 1: a potential marker for the prediction of environmental carcinogenesis risk", Oxid Med Cell Longev, 2014, pp.730301~ (2014)
- Wang M, "Genetic variants of XRCC1, APE1, and ADPRT genes and risk of bladder cancer", DNA Cell Biol, 29, pp.303~311 (2010)
- Huang M, "High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility", Cancer Epidemiol Biomarkers Prev, 16, pp.84~91 (2007)
- 신주현, "APE1", Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer, 2015, pp.47(4), 823~833[DOI]
- Choi S, "Urinary APE1", Ref-1: a Potential Bladder Cancer Biomarker, 2016, pp.2016, 7276502~
- Choi S, "Histone deacetylases inhibitor trichostatin A modulates the extracellular release of APE1", Ref-1, 2013, pp.435, 403~407
- Lee YR, "Extracellularly secreted APE1", Ref-1 triggers apoptosis in triple-negative breast cancer cells via RAGE binding, which is mediated through acetylation, 2015, pp.6, 23383~23398
- Park MS, "Secreted APE1", Ref-1 inhibits TNF-α-stimulated endothelial inflammation via thiol-disulfide exchange in TNF receptor, 2016, pp.6, 23015~
- 박명수, "Cytoplasmic Localization and Redox Cysteine Residue of APE1", Ref-1 Are Associated with Its Anti-Inflammatory Activity in Cultured Endothelial Cells, 2013, pp.36(5), 439~445[DOI]
- 정진옥, "Elevation of the Serum Apurinic", Apyrimidinic Endonuclease 1, Korean Circulation Journal, pp.2015, 45(5)[DOI]
- Friedberg EC, "The role of endogenous and exogenous DNA damage and mutagenesis", Curr Opin Genet Dev, 14, pp.5~10 (2004)
- Wilson DM 3rd, "Life without DNA repair", Proc Natl Acad Sci U S A, 94, pp.12754~12757 (1997)
- Lin CH, "The APE1 Asp", Asp genotype and the combination of APE1 Asp, J Epidemiol, pp.2012, 22[DOI]
- Canbay E, "Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population", Curr Med Res Opin, 27, pp.1295~1302 (2011)
- Hu D, "APEX nuclease (multifunctional DNA repair enzyme) 1 gene Asp148Glu polymorphism and cancer risk: a meta-analysis involving 58 articles and 48903participants", PLoS One, 8, pp.e83527~ (2013)
- Jackson EB, "Analysis of nuclear transport signals in the human apurinic", apyrimidinic endonuclease (APE1, Nucleic Acids Res, pp.2005, 33[DOI]
- Qu J, "Nitric oxide controls nuclear export of APE1", Ref-1 through S-nitrosation of cysteines 93 and 310, 2007, pp.35, 2522~2532
- AlMutairi F, "Association of DNA repair gene APE1 Asp148Glu polymorphism with breast cancer risk", Dis Markers, 2015, pp.869512~ (2015)
- Hadi MZ, "Functional characterization of Ape1 variants identified in the human population", Nucleic Acids Res, 28, pp.3871~3879 (2000)
- Bhakat KK, "Role of acetylated human AP-endonuclease (APE1", Ref-1) in regulation of the parathyroid hormone gene, 2003, pp.22, 6299~6309
- Yamamori T, "SIRT1 deacetylates APE1 and regulates cellular base excision repair", Nucleic Acids Res, 38, pp.832~845 (2010)
- Jung SB, "Redox factor-1 activates endothelial SIRTUIN1 through reduction of conserved cysteine sulfhydryls in its deacetylase domain", PLoS One, 8, pp.e65415~ (2013)